On June 12, 2017, Hubei Mengyang Pharmaceutical Co., Ltd. held a project demonstration meeting in Beijing led by Professor Lin Hongsheng of Guang'anmen Hospital of China Academy of Chinese Medical Sciences to apply for the key special project of "Modernization Research of Traditional Chinese Medicine" of the Ministry of Science and Technology of the People's Republic of China, "Re-evaluation of the effectiveness and safety of Shengbai Oral Liquid in the prevention and treatment of tumor radiotherapy and chemotherapy leukopenia".

The scene of the project demonstration meeting

Professor Lin Hongsheng elaborated on the content of the topic

The experts who attended the meeting included Professor Lin Hongsheng of Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Professor Shen Lin and Professor Li Pingping of Peking University Cancer Hospital, Professor Yang Guowang of Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Professor Li Jie and Professor Liu Jie of Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Zhang Min, chairman of Mengyang Pharmaceutical, Zhou Huiying, assistant to the general manager, Wang Yongjun, director of medical marketing, and Xiong Chuanjun, general manager of Beijing Office, attended the meeting.

Professor Shen Lin

Professor Li Pingping

Professor Yang Guowang

At the beginning of the meeting, Chairman Zhang Min introduced the current situation and development plan of Mengyang Pharmaceutical to the participating experts, and Professor Liu Jie introduced the scientific research project plan of this project.

During the on-site discussion session, the atmosphere was quite lively

After the discussion of experts in traditional Chinese medicine, Western medicine and integrated traditional Chinese and Western medicine, everyone agreed that in terms of improving the clinical research height of Shengbai oral liquid, it is necessary to apply modern means to conduct comprehensive evaluation, extend from treatment to prevention, improve the body's immunity, and comprehensively improve patients' symptoms will be the best interpretation of the overall view of traditional Chinese medicine, which is the concrete embodiment of the modernization of traditional Chinese medicine. The experts at the meeting also gave guidance on the selection of diseases in the topic, the age of enrollment, the improvement of symptoms and syndromes, immune indicators, quantifiable indicators and other specific details. It is the upcoming national multi-center clinical study of raw white oral liquid